Recent investigations have indicated that one way in which to achieve selectively toxic antimetabolites is to find a biological precursor of a vitamin, and then to construct a suitable analog of it. Such an analog may then harm those species which synthesize this vitamin, and should not affect those which have a nutritional requirement for it. Thus, the selective toxicity of sulfanilamide and its congeners for certain bacteria in contrast to higher animals has been postulated to reside in the difference in requirement for folic acid (1-3). This postulate has received support in the finding that the harmful action of a pimelic acid analog could be foretold with fair precision from a knowledge of nutritional requirements for biotin (4). The vitamin which arises from the precursor by a series of biosynthetic reactions (e.g., biotin) sometimes may be able completely and non-competitively to erase the effects of the analog.
and then to construct a suitable analog of it. Such an analog may then harm those species which synthesize this vitamin, and should not affect those which have a nutritional requirement for it. Thus, the selective toxicity of sulfanilamide and its congeners for certain bacteria in contrast to higher animals has been postulated to reside in the difference in requirement for folic acid (1) (2) (3) . This postulate has received support in the finding that the harmful action of a pimelic acid analog could be foretold with fair precision from a knowledge of nutritional requirements for biotin (4) . The vitamin which arises from the precursor by a series of biosynthetic reactions (e.g., biotin) sometimes may be able completely and non-competitively to erase the effects of the analog.
The present investigation was undertaken with two questions in mind. (a) Could additional substances of predictable selective toxicity be realized by construction of structural analogs of a precursor of another vitamin? (b) Could a means be found to foretell antimetabolites of the precursor which would not be counteracted by the vitamin?
With regard to the first question, the correlation of the selective toxicity of sulfanilamide and of the pimelic acid analog with nutritional requirements for the vitamins, folic acid or biotin, was just cited. In the present study a single precursor of both riboflavin and vitamin B~2 was sought, an analog of this precursor was prepared, and it has been shown to retard the growth of all species examined except those with a nutritional need for these two vitamins. This demonstration added evidence in favor of the postulate that selectively toxic substances can be achieved in this general way.
The bearing of the second question on some of the problems of chemotherapy and of pharmacology can be seen from consideration of the action of sulfanilamide, in contrast to that of the pimelic acid analog mentioned above. This latter antimetabolite retarded the growth of biotin-synthesizing organisms, and this action was overcome competitively by pimelic acid (4) . Such organisms have been shown probably to carry out the formation of biotin by a series of reactions starting with pimelic acid (5, 6) . The growth retardation is therefore probably due to an interference with this synthesis. In accord with this opinion it was found that if biotin was present in the culture fluid, the pimelic acid analog was no longer toxic. Similarly, those species which lacked the ability to synthesize biotin, and depended on their food for it, were not susceptible to the toxicity of the analog.
Nevertheless, the ability to counteract the analog with the vitamin related to it further up the biosynthetic pathway probably accounts in part for the failure of such compounds as therapeutic agents in infectious diseases. In such chemotherapy it is necessary to retard one species selectively when it is growing in mixed culture with another (i.e., the host animal). This is a considerably more exacting task than is the selective inhibition of isolated species. In terms of the example with the pimelic acid analog, biotin-independent forms can be affected, and biotin-dependent ones are not when tested singly. However, when tested in mixed culture, the biotin needed to secure any growth of the latter forms negates the action of the analog on the former ones. As a result, neither is harmed. This has proved to be true experimentally. Thus, although mice were resistant to this pimelic acid analog, and tubercle bacilli were quite susceptible, it was found incapable of saving mice from mortal infection with tubercle bacilli (7) . The biotin within the animals probably nullified the antibacterial power of the compound. Of course, this explanation is not the only one which may apply, but it seems the most plausible one in view of existing knowledge.
The chemotherapeutic action of sulfanilamide indicates the probable point of difference of a successful drug from one which is not so. This analog of p-aminobenzoic acid would be expected to be counteracted by folic acid, the product somewhat further up the biosynthetic path. However, in practically all cases this is not found to be the case. Only in the case of a few species of enteric streptococci will folic acid nullify the antibacterial action of the sulfonamide drugs (2, 8) . These organisms are among those which are resistant to sulfonamide therapy when they invade animal tissues. Perhaps the folic acid in these tissues accounts for the failure of the drugs to act. When grown in isolated culture in the absence of excess folic acid, the enteric streptococci are susceptible to sulfanilamide (2) . The chemotherapeutic successor sulfonamide drugs thus may depend on an inability of folic acid to erase its antibacterial powers, just as the chemotherapeutic failure of the pimelic acid analog may be related to the ability of biotin to do so. The problem then is to understand the basis of this difference, or failing that, to comprehend enough of it to provide conditions favorable to the formation of similarly irreversible agents which will act in mixed cultures.
The working hypothesis which has been explored in this study is that selectively acting compounds which are not nullified by vitamins further along the biosynthetic path, can be made by choice of a metabolic precursor of t w o or m o r e vitamins and production of a suitable analog of this precursor. The desirable type of action of sulfanilamide is believed to reside in such a situation. It is an analog of p-aminobenzoic acid, which is a precursor of folic acid, and possibly of some other essential metabolite as well. These other essential metabolites are not considered to be the purines, serine, or valine (9), because, although the latter influence the action of sulfanilamide, the bulk of evidence points to the conclusion that they are products arising from reactions of folic acid, and hence only secondarily from p-aminobenzoic acid. (See for example references 10-12.) It is not possible to give any well documented reason why an analog of a precursor of two or more vitamins should act in the desired irreversible fashion. One might expect a mixture of these two or more metabolites to erase the effect just as biotin does for the pimelic acid analog. Although to support the postulate an argument can be constructed which is based on competing rates of reaction for the precursor and on differences in the way the two vitamins are metabolized, sufficient data are not available to make it definitive.
The working hypothesis can b~ tested in the following way. A precursor of two or more vitamins should be sought, and an antimetabolite of it should be made. This antimetabolite ought then to prove harmful to species which do not have a nutritional need for both of these vitamins, and harmless to those which require them. Furthermore, both vitamins should be unable to nullify the toxic effect of the analog, while the precursor to which it is structurally related should do so competitively.
1,2-Dimethyl-4,5-diaminobenzene was recognized as a probable precursor of riboflavin and of vitamin BI~, and some evidence for this opinion was found. This diamine occurs in riboflavin fused to a pyrimidine ring and a ribityl side chain. It has also been identified in vitamin BI~ as part of a dimethylbenzimidazole riboside which occurs in acid hydrolysates of the vitamin (13) . An antimetabolite of it, namely 1,2-dichloro-4,5-diaminobenzene showed those biological properties expected of such an analog. Eighteen gin. of 1,2-dichloro-4, 5-dinitrobenzene (15) was suspended in 120 cc. of concentrated HCI, the mixture was heated on a steam bath, and 30 gin. of mossy fin was added slowly. The mixture was shaken vigorously during the addition of the tin, and the flask was equipped with an air condenser during the operation. When the order of addition was changed, the product was black, and difficult to purify. The mixture was heated for half an hour on the steam bath after all the tin had been introduced, and then 200 cc. of water and about 3 gin.
of norit were added. The mixture was filtered while it was still hot, and the colorless filtrate was concentrated under reduced pressure until extensive crystallization had occurred (to about 100 cc.). The mixture was cooled and saturated with HCI gas and the crystals were collected, washed with concentrated HCI, and recrystallized from 50 cc. of water by saturating the solution with HC1. The yield was 13.4 gin. of white needles. When heated on a microscope stage the shape of the crystals changed at about 155 ° from needles to plates, and these melted with decomposition at 193 °. These values were unchanged by recrystallization.
CsH~N~CI4. Calculated, N 11.2; found, N 11.3 A substance with the same characteristics was formed when 1,2-dichloro-4-amino-5-nitrobenzene was similarly reduced with tin and HC1. The starting material for both routes was 1,2-dichloro-4-nitrobenzene. The direct nitration required in the first method limited the scale of the operations, but the over-all yield was better than by the second procedure.
The free base was obtained by solution of the dihydrochloride in water, addition of an excess of 1 ~ NaOH, and extraction with ether. Evaporation of the ether from the extract left white or pink crystals which were purified by recrystallization from hot water. These crystals began to shrink at about 130 ° and slowly changed as the temperature was raised, until they had disappeared at about 160 ° .
CsHgNT2C12. Calculated, C 40. 
Manner of Testing Effect of Analog on Growth of Microorganisms.--A culture medium ade-
quate for the growth of the species under observation was distributed in 10 cc. portions in test tubes, and sterilized at 120 °. Neutralized, aqueous solutions of the dichlorodiaminobenzene dihydrochloride were sterilized separately, and added aseptically just before inoculation. Sufficient water was omitted from the tubes in a series to allow for this addition. The heating of any phenylenediamine derivative in the basal media was avoided. The cells from a young broth culture of the organism were washed once, and diluted to 1/100 of their original concentration, and 1 drop was used to inoculate each tube. Incubation at the temperature best suited to each species was continued until maximal growth was observed in the unsupplemented basal medium. Prolonged incubation invariably made the diamine appear less toxic. The amount of growth was determined by measurement of turbidity in an Evelyn colorimeter, and in addition, where this could be done, by titration of the acid produced. Dose-response curves were constructed, and from them the amount of substance which allowed half-maximal growth was estimated.
The basal medium employed for nearly all species was that of Landy and Dicken (16) in which folic acid was supplied as pteroyl glutamic acid (0.01 "y per co.), and in which riboflavin was present in 0.1 ,/per cc. An effort was made to use the same basal medium for all species in order to eliminate the chance of differences in toxicity arising from dissimilarities of the culture fluid. However, for a few of the species special media were necessary to secure growth.
For O. multlannulatum the one described by Fries et al. (17) was used, and for Saccharomyces cereviseae, one developed earlier (18) was employed. Because P. tabaci and P. angulata failed to grow in the enriched medium of Landy and Dicken, tests with these organisms were done in the mixture of glucose and salts proposed by Hook a d. (19) . For L. lactis (Dorner) and L. le/chmanni a tryptic digest of casein (0.5 mg. per cc.) and crystalline vitamin Bl2 (0.003 ~, per cc.) 1 were added to the Landy-Dicken medium as recommended by Hoffmann e/at. (20) . This was done in preference to use of the solution proposed by these authors, because the concentration of heavy-metal salts which they employed was great enough to cause darkening and precipitation of the dichlorodiaminobenzene. In order to induce L. bifMis to grow in this medium, the increased vitamin levels used by Skeggs a d. (21) were employed. The effects of such additions to the medium of Landy and Dicken, on the toxicity of the analog for Staphyloceccus aureus, and for L. case/and for E. coli were found to be negligible in comparative trials.
Therefore, these alterations did not seem to be of great importance for the values observed. Similarly, vitamin BI~ did not influence the toxicity for any species except the two to be discussed below. Those organisms which did not require the presence of riboflavin were tested with the analog in the absence of this vitamin as well as with 0.1 3' of it per cc., but the resuits were comparable. E. gracilis and C. vulgarls were grown in the medium described by Hutner et al. (22) . The requirements of each species for riboflavin and for vitamin B12 were determined in these media by omission of one or the other and observation of growth response in comparison to a supplemented control in the usual fashion. Table I illustrate the effect of the analog on the growth of S. aureus when the test was conducted in the manner just indicated. Halfmaximal inhibition was achieved with 6 3" per cc. I n a series of similar trials, the value varied from 5 to 10 3/depending somewhat on the time of incubation.
Selective Toxicity of 1,2-Dichloro-4,5-diaminobemene Correlated with Nutritional Requirements for Riboflavin and Vitamin
Bl~.--When a number of microbial species were examined in the m a n n e r just indicated, the toxicity of the analog for each was found to be as shown in Table II . The requirements for riboflavin and for vitamin B12 were also observed to be as indicated there, and these were in close agreement with existing knowledge about such needs. The maximal concentration of the dichlorodiaminobenzene dihydrochloride which could be tested was 300 3' per cc., because with larger amounts a precipitate formed during the incubation period.
Those species which required both vitamins were insusceptible to the growth- 
t y p h i m u r i u m , S . s o n n e i , and P r o t e u s )
were considerably more resistant than other forms which showed no nutritional need for riboflavin and v i t a m i n Bt~. This was noteworthy in view of a somewhat similar situation with respect to the comparative resistance of such species to sulfanilamide. The organisms which required only one of the two vitamins preformed in the medium tended to be more resistant than closely related species which required neither, but they were still affected by the analog when present in sufficient concentration. Thus L. casei was somewhat more resistant than L. arabinosus, and E. gracilis was more so than C. vulgaris. However, the number of such species was not large enough to warrant a sound conclusion on this point. The correlation of susceptibility and nutritional need for riboflavin and vitamin B19 appeared to best advantage when the different lactobacilli were compared. Among this group of physiologically and morphologically related species those which showed the nutritional requirements were quite resistant, while those which did not were among the most susceptible.
Tolerance of Mice for 1,2-Dichloro-4,5-diaminobenzene.--This compound
was relatively non-toxic to mice. For these tests Swiss strain albino animals ranging in age from 4 to 12 weeks were usually employed, but other strains were also tested with entirely similar results. All animals were fed a stock ration (purina fox chow). Eleven individuals injected daily with an aqueous solution of 10 rag. of the dihydrochloride for 10 days showed no detectable sign of injury. Sixteen animals responded similarly when the dihydrochloride was made to constitute 0.5 per cent of the food, and in addition, were injected daily intraperitoneally with 6 rag. of the free base dissolved in olive oil. This combined treatment was continued for 1 month, during which time the animals gained weight.
Competitive Antagonism of the Action of the Dichlorodiaminobenzene with 1,2-Dimethyl-4 ,Y-diaminobenzene in Bacteria.--The growth-inhibiting proper-
ties of the dichloro compound were antagonized, and in a competitive fashion, by 1,2-dimethyl-4,5-diaminobenzene, ~ the postulated metabolic precursor to which the halogenated analog was structurally related. The data in Table III illustrate this point in the case of S. aureus. A similar situation was found with each one of the susceptible species, except with the Gram-negative enteric bacilli, which were not tested in this way.
The concentration of dimethyldiaminobenzene required to antagonize the action of the dichloro analog was somewhat greater than that which might be expected if the former were a true metabolic precursor of the 2 vitamins under consideration. Thus, to antagonize a minimally inhibitory amount of the dichloro compound in S. aureus about 1 3, of the dimethyldiaminobenzene per cc. was demanded. By analogy with the sulfanilamide-p-aminobenzoie acid case, one would expect considerably less to be effective. Furthermore the dimethyldiaminobenzene was itself toxic in all species tested when sufficiently high concentrations were employed. Thus, 200 3, per cc. caused half-maximal inhibition of the growth of S. aureus. This toxicity may be reminiscent of the antimicrobial effect exerted by high concentrations of p-aminobenzoic acid. * This is the amount necessary to antagonize the dimethyldiamine added to the medium and is column 2 minus the amount of dichloro analog found necessary with no added dimethyl compound. Table IV . Because o-phenylenediamine was itself toxic above 20 3" per cc. no more extensive study of its apparently competitive behavior could be made.
A ntagonism

Activity of 1,2-Dimethyl-4 ,5-diaminobenzene in Replacement of Riboflavin and Vitamin
Bx2.--The dimethyldiaminobenzene exhibited some slight activity as riboflavin when tested with L. casei, and some potency as vitamin BI~ for L. leicttmanni, and for E. gracilis. The assays for riboflavin activity were performed in the basal medium described earlier in this paper, from which riboflavin was omitted. The methods of Hutner et al. (22) and of Hoffmann et et. (20) were employed for vitamin B12. The diamines to be tested were added after the media had been sterilized. 1,2-Dimethyl-4,5-diaminobenzene was 1/100,000 as active as riboflavin for L. casei, and 1/1,000,000 as active as vitamin Bz~ for L. leichmanni. For E. gracilis it was between 1/500,000 and 1/1,000,000 as potent as vitamin B1,. In all assays, full growth could not be attained with the compound because its limited solubility restricted the amount which could be added. The comparisons of activity with the two vitamins were therefore made only on the lower portion of the standard doseresponse curves.
1,2-Dimethyl-4-amiuo-5-ribitylaminobenzene 3 was similarly tested. It proved to have no activity for vitamin Bn, but was 1/10,000 as effective as riboflavin for L. casei. This compound is one stage nearer to riboflavin than is the dimethyldiaminobenzene, but is somewhat more removed from vitamin Bxv Riboflavin activity for it has been observed previously (23) . The effect was observable only at levels of the latter which still permitted fair growth in the absence of the additional riboflavin and the B12. An amount of the dichloro compound which was able to suppress growth completely could not thus be rendered less harmful. The data in Table V illustrate these facts. The magnitude of this antagonism was such as to raise doubts about its existence but the effect was observed regularly.
Effect of Riboflavin Plus
Excessive amounts of riboflavin (10 3" per cc. of culture medium) inhibited the growth of some of the species, e.g., S. aureus. These harmful concentrations of the vitamin enhanced rather than diminished the toxicity of the dichlorodiaminobenzene. This was found to be the case whether vitamin B12 was present or absent. vitamin BI~ in the medium in this way would render this species susceptible to the dichlorodiaminobenzene. Vitamin B12 was therefore omitted, and desoxyguanosine (10 "r per cc.) was added to the basal medium. Under these condition~ 300 3' of the analog per cc. did not retard growth. The result was the sam~ when desoxyinosine was used in place of desoxyguanosine.
Effect of Replacement of Vitamin
The experiments were repeated with L. leichraanni strain 313. However, in contrast to reports in the literature (24) , neither desoxyguanosine nor desoxyinosine would support growth in the absence of vitamin Bu. Therefore a trial with the dichlorodiamine was not possible. The success in predicting what species would be susceptible to 1,2-dichloro-4,5-diaminobenzene from a consideration of nutritional requirements adds more support to the postulate that selectively toxic substances can be realized in the same way. Similarly, the results harmonize with the idea that agents may be formed which are not counteracted by substances further up the biosynthetic metabolic path if a metabolite is chosen which is the precursor of two or more of them. This latter point is still quite tenuous, and requires much further exploration. Several parts of the argument lack sufficient experimental support. In the first place, no convincing evidence was found that 1,2-dimethyl-4,5-diaminobenzene actually is the metabolic precursor of riboflavin and vitamin B12. Points in favor of its being such are (a) its undeniable occurrence in the two vitamins, (b) its slight activity in replacement of each of these two vitamins, and (c) its ability to counteract in a competitive fashion the toxicity of 1,2-dichloro-4,5-diaminobenzene. Data difficult to reconcile with such a view are (a) that it is not more active in counteracting the harmful effects of the dichloro analog, and (b) that o-phenylenediamine will overcome the toxicity of the dichlorodiaminobenzene.
If the concept outlined in this paper is correct, then clearly some discrimination must be exercised in its application to other cases. The choice of the metabolic precursor may be important, because present knowledge indicates that just any one will not do, even though it may be the starting point for the formation of two or more important constituents of living cells. Thus, glutamic acid is most probably used in the synthesis of both glutamine and glutathione, and possibly of several more metabolites as well. And yet, structural analogs of glutamic acid have not proven to be selectively harmful to those species which perform the syntheses of these compounds. Indiscriminate application of the present concept would require them to do so.
The bases for a discriminating choice do not seem clear. Perhaps, if one wishes to inhibit cell division, one should select a precursor of some of those substances which are directly concerned in cell division, rather than in some other processes such as energy transport or the building of anatomical structures. In any event, metabolic precursors do not appear to be of equal aptitude for this purpose.
It is quite conceivable that the toxicity of dichlorodiaminobenzene has no relationship to the biosynthesis of riboflavin and of vitamin BI~. The antagonism of its effect with the dimethyldiaminobenzene could then be viewed as follows: Cells possess a mechanism for metabolizing aromatic amines, which are poisonous for unknown reasons. The dimethyldiamine is intrinsically less toxic than the dichlorodiamine. (This has actually proved to be the case.) The less toxic dimethyl compound may thus be able to exclude the more harmful dichloro compound and thus protect the cell. While such a view is tenable, it seems less likely than the other one proposed, especially in light of the correlations of toxicity with nutritional needs for two vitamins which possess the dimethyldiaminobenzene structure within them.
SUM-I~d~Y
In a series of 26 species selected from widely differing classes, 1,2-dichloro-4,5-diaminobenzene was toxic to those which did not exhibit a nutritional need for riboflavin plus vitamin Bu. It failed to retard the growth of those which needed both of these vitamins. The compound was conceived as an antimetabolite of 1,2-dimethyl-4,5-diaminobenzene. This latter, which is contained within the structures of the two vitamins, was pictured as a metabolic precursor of them. It was found to have very slight activity as either riboflavin or as vitamin BI2 for lactic acid bacteria and algae. The growth-inhibiting action of the dichlorodiaminobenzene was overcome competitively by the dimethyldiaminobenzene, and also, to a lesser extent, by o-phenylenediamine. The toxicity was not influenced by additions of riboflavin plus vitamin B,2, except in the cases of two species, where the influence was slight. These facts were considered to support the idea that properly constructed analogs of a precursor of two or more essential participants in cell division may be able to
